Showing results (1-10 of 500) with videos related to
Sort By:
Pageof 50
Blood Reviews|November 25, 2010
State of the art treatment of chronic lymphocytic leukaemiaMichael Hallek, Natali PflugAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Chronic lymphocytic leukemiaMichael Hallek, Natali PflugTherapeutic Advances in Hematology|June 2, 2017
Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective reviewOthman Al-Sawaf, Paula Cramer, Valentin Goede, et al.Drug Design, Development and Therapy|February 10, 2017
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapyOthman Al-Sawaf, Kirsten Fischer, Anja Engelke, et al.Annals of Hematology|December 3, 2016
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AMLUdo Holtick, Marco Herling, Natali Pflug, et al.Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.Leukemia|March 7, 2025
Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunityHanna Klepzig, Marco Herling, Natali Pflug, et al.Best Practice & Research. Clinical Haematology|July 13, 2010
Therapy of chronic lymphocytic leukaemiaMichael HallekHematology. American Society of Hematology. Education Program|November 24, 2005
Chronic lymphocytic leukemia (CLL): first-line treatmentMichael Hallek, Hematology. American Society of Hematology. Education Program|December 10, 2013
Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategiesMichael HallekPageof 50